BofA lowered the firm’s price target on Thermo Fisher (TMO) to $660 from $675 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech ...
BofA lowered the firm’s price target on Thermo Fisher (TMO) to $545 from $680 and keeps a Buy rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research Organizations ...
Wells Fargo raised the firm’s price target on Thermo Fisher (TMO) to $680 from $660 and keeps an Overweight rating on the shares. Core growth is steadily improving quarter-over-quarter and 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results